Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aarti Drugs Limited Call Transcript 2023

Jul 18, 2023

62194_rns_2023-07-18_12608fea-489f-400a-a4d7-cde15d98cb8e.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [512 x 106] intentionally omitted <==

Ref: ADL/SE/2023-24/44 July 18, 2023

To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, “Exchange Plaza”, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051 NSE SYMBOL: AARTIDRUGS BSE CODE – 524348

Dear Sir/Madam,

Ref : Regulation 30(6) of SEBI (LODR) Regulations, 2015 Sub: Intimation of Conference Call

This is to inform you that Quarterly Earning Conference Call for the Investors and Analysts has been scheduled on Monday, July 24, 2023 at 11:00 A.M. IST to discuss the Company’s financial performance for the Quarter ended June 30, 2023. Please find attached herewith invitation for the same.

Kindly take the same on record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED

RUSHIKESH VIVEK DEOLE Digitally signed by RUSHIKESH VIVEK DEOLE DN: c=IN, o=PERSONAL, title=5599, pseudonym=52288d43536c4230831c2e75cd4b8c59, 2.5.4.20=073813c4edff683f8b6ec3cb4e69ca6d8d4f7258a44f635abc18581eaa522821, postalCode=421301, st=Maharashtra, serialNumber=9b60f64457feab7f455d17463ebe710861bf01b575f6fc0484483273dabfc17f, cn=RUSHIKESH VIVEK DEOLE Date: 2023.07.18 21:06:14 +05'30'

RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527

==> picture [468 x 29] intentionally omitted <==

==> picture [287 x 50] intentionally omitted <==

Aarti Drugs Limited Q1 FY24 Earnings Conference Call

DATE & TIME 24[th] July 2023 (Monday) 11:00 am, IST (HK/Singapore 1:30 pm, UK 6:30 am, USA 1:30 am EST)

PARTICIPANTS

Mr. Harshit Savla – Jt. Managing Director Mr. Harit Shah – Executive Director

Mr. Adhish Patil – Chief Financial Officer & Chief Operating Officer

Mr. Vishwa Savla – Managing Director, Pinnacle Life Science Private Limited

PRE REGISTRATION LINK – CLICK HERE

CONFERENCE DIAL IN DETAILS

INDIA +91 22 6280 1309 / +91 22 7115 8210 UNITED STATES 1 866 746 2133 UNITED KINGDOM 0 808 101 1573 SINGAPORE 800 101 2045 HONG KONG 800 964 448

RSVP:

Strategic Growth Advisors Pvt. Ltd.

Mr. Deven Dhruva / Mr. Harsh Shah Contact: +91 98333 73300 / +91 97689 74808